Home Business NewsBusiness GSK sells vaccines to rival for £822m

GSK sells vaccines to rival for £822m

by LLB Editor
21st Oct 19 9:45 am

GlaxoSmithKline, the pharmaceutical giant, says it will sell two travel vaccines to a rival for €955m (£822m) as it plans to invest more in cancer treatments.

It sold Rabipur, which is a vaccine against rabies and Encepur, which is to prevent of tick-borne encephalitis, to Bavarian Nordic.

GSK bought the treatments from Novartis in 2015.

Leave a Comment

You may also like


Sign up to our daily news alerts

[ms-form id=1]